JP2006502129A5 - - Google Patents

Download PDF

Info

Publication number
JP2006502129A5
JP2006502129A5 JP2004526493A JP2004526493A JP2006502129A5 JP 2006502129 A5 JP2006502129 A5 JP 2006502129A5 JP 2004526493 A JP2004526493 A JP 2004526493A JP 2004526493 A JP2004526493 A JP 2004526493A JP 2006502129 A5 JP2006502129 A5 JP 2006502129A5
Authority
JP
Japan
Prior art keywords
sulfated polysaccharide
infection
humans
mol
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004526493A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006502129A (ja
Filing date
Publication date
Priority claimed from US10/321,756 external-priority patent/US20030181416A1/en
Application filed filed Critical
Publication of JP2006502129A publication Critical patent/JP2006502129A/ja
Publication of JP2006502129A5 publication Critical patent/JP2006502129A5/ja
Withdrawn legal-status Critical Current

Links

JP2004526493A 2002-08-13 2003-04-24 腎臓濾過および腎臓通過中のリソソーム分解に対して耐性を示す抗微生物性荷電ポリマー、その組成物および使用方法 Withdrawn JP2006502129A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40269502P 2002-08-13 2002-08-13
US10/321,756 US20030181416A1 (en) 2002-01-10 2002-12-17 Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
PCT/AU2003/000488 WO2004014400A1 (en) 2002-08-13 2003-04-24 Antimicrobial charged polymers that exhibit resistance to lysomal degradation during kidney filtration and renal passage, compositions and method of use thereof

Publications (2)

Publication Number Publication Date
JP2006502129A JP2006502129A (ja) 2006-01-19
JP2006502129A5 true JP2006502129A5 (enExample) 2006-06-15

Family

ID=31720276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004526493A Withdrawn JP2006502129A (ja) 2002-08-13 2003-04-24 腎臓濾過および腎臓通過中のリソソーム分解に対して耐性を示す抗微生物性荷電ポリマー、その組成物および使用方法

Country Status (6)

Country Link
US (2) US20030181416A1 (enExample)
EP (1) EP1534303A4 (enExample)
JP (1) JP2006502129A (enExample)
AU (1) AU2003218910A1 (enExample)
CA (1) CA2495116A1 (enExample)
WO (1) WO2004014400A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
US7499433B2 (en) * 2002-11-19 2009-03-03 Alcatel-Lucent Usa Inc. Method and apparatus for DTX frame detection
US20050009782A1 (en) * 2003-07-09 2005-01-13 Comper Wayne D. Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
ES2251289B1 (es) * 2004-02-27 2007-07-01 Bioiberica, S.A. Nuevo uso terapeutico de un grupo de polisacaridos sulfatados.
US20060154895A1 (en) * 2004-12-09 2006-07-13 Maxwell Gordon Method of treating acquired immunedeficiency syndrome
FR2881051A1 (fr) * 2005-01-27 2006-07-28 Therapol Sa Utilisation de fucanes selectionnes pour la preparation d'un materiau bacteriophobe et bacteriostatique, materiau correspondant et applications
US9358150B2 (en) 2005-05-13 2016-06-07 Benechill, Inc. Methods and devices for non-invasive cerebral and systemic cooling alternating liquid mist/gas for induction and gas for maintenance
US7824436B2 (en) * 2005-05-13 2010-11-02 Benechill, Inc. Methods and devices for non-invasive cerebral and systemic cooling
US8721699B2 (en) 2005-05-13 2014-05-13 Benechill, Inc. Methods and devices for non-invasive cerebral and systemic cooling
EP2007401A2 (en) * 2006-04-04 2008-12-31 Marinomed Biotechnologie GmbH Anti-inflammatory polymer
EP1842545A1 (en) * 2006-04-04 2007-10-10 Marinomed Biotechnologie GmbH Anti-inflammatory polymer
EP3144324A1 (en) 2006-06-02 2017-03-22 Synedgen, Inc. Chitosan-derivative compounds and methods of controlling microbial populations
US20080248508A1 (en) * 2006-08-17 2008-10-09 Shenda Baker Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials
US7981930B2 (en) * 2007-03-13 2011-07-19 Adamas Pharmaceuticals, Inc. Compositions and kits for treating influenza
HRP20130402T1 (hr) * 2007-08-24 2013-06-30 Marinomed Biotechnologie Gmbh Antivirusni pripravak koji sadrži sulfatirani polisaharid: jota-karagenan
WO2010054249A1 (en) * 2008-11-07 2010-05-14 Benechill, Inc. Methods of nasopharyngeal cooling for augmenting coronary perfusion pressure
US8697670B2 (en) 2009-01-28 2014-04-15 Life Science Nutrition As Compositions and methods of treating viral infections
US8157767B2 (en) 2009-06-19 2012-04-17 Benechill, Inc. Devices for cooling the nasal cavity
CA3004707C (en) 2009-09-02 2022-05-31 Synedgen Inc. Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds
WO2011100805A1 (en) * 2010-02-22 2011-08-25 Marinova Pty Ltd Anti-viral formulations
EP2663338B1 (en) * 2011-01-14 2024-03-06 Emory University Glucose-based oligosaccharides comprising a positron-emitting radionuclide and their use for imaging
US20140046052A1 (en) * 2011-09-21 2014-02-13 Bruce A. Daniels Therapeutic Sulfated Polysaccharides, Compositions Thereof, and Methods for Treating Patients
WO2014036165A1 (en) * 2012-08-29 2014-03-06 Bayer Healthcare, Llc Aqueous based compositions for treating otitis externa
FR2998176B1 (fr) 2012-11-16 2015-01-16 Univ Blaise Pascal Clermont Ii Composition de polysaccharide sulfate
FR3013223B1 (fr) * 2013-11-18 2016-09-02 Amadeite Extrait d'algues pour son utilisation en tant qu'agent anti-bacterien
CA2960998A1 (en) 2014-09-11 2016-03-17 Synedgen, Inc. Compositions and methods of use thereof
US20170232079A1 (en) * 2015-10-06 2017-08-17 Kieu Hoang Method of manufacturing prothrombin complex concentrate from fraction iii and non-prothrombin complex concentrate from fraction iv
CN105560983A (zh) * 2016-01-04 2016-05-11 成都富豪斯生物科技有限公司 一种治疗风痰壅盛及头晕目眩的丸剂药物及其制备方法
CN105477011B (zh) * 2016-01-08 2018-02-27 中山大学 卡拉胶Carrageenan在防治猪蓝耳病中的应用
MX392702B (es) * 2016-05-26 2025-03-24 Paradigm Biopharmaceuticals Ltd Sal sódica de polisulfato de pentosán para usarse en la reducción de dolor por inflamación inducida por virus del río ross, virus chikungunya y virus del bosque barmah en un individuo humano.
JP7112409B2 (ja) * 2017-01-24 2022-08-03 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 抗Ｆｅｌ Ｄ１抗体を含む組成物及びヒトのネコアレルギーの少なくとも１つの症状を減少させる方法
CN109820877B (zh) * 2019-04-12 2021-03-30 南华大学 一种构建梅毒螺旋体小鼠模型的方法
CN110663685B (zh) * 2019-10-23 2021-10-12 扬州大学 一种介孔二氧化硅负载ppte的纳米农药制剂
WO2021203174A1 (en) * 2020-04-09 2021-10-14 Paradigm Biopharmaceuticals Ltd Treatment of acute respiratory distress syndrome (ards) with polysulfated polysaccharides
AU2021255044A1 (en) * 2020-04-15 2022-11-10 Tx Medic Ab Treatment of coronavirus infections
WO2021221656A1 (en) 2020-04-30 2021-11-04 Synedgen, Inc. Compositions and methods of use thereof

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE598328A (enExample) * 1959-12-18
US3141014A (en) * 1960-03-31 1964-07-14 Meito Sangyo Kk Sodium and potassium salts of the dextran sulphuric acid ester having substantially no anticoagulant activity but having lipolytic activity and the method of preparation thereof
US3414014A (en) * 1965-03-23 1968-12-03 American & Standard Inc Expansion valve
US3536809A (en) * 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3948913A (en) * 1971-04-27 1976-04-06 Ciba-Geigy Corporation New 5-nitrofuryl derivatives
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) * 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
ZA791659B (en) * 1978-04-17 1980-04-30 Ici Ltd Process and apparatus for spraying liquid
DE3124384C2 (de) * 1981-06-22 1985-05-15 Herbert Prof. Dr. 1000 Berlin Voß Dermatanpolysulfat, Verfahren zu dessen Herstellung und dieses enthaltendes virushemmendes Mittel
US4948881A (en) * 1982-12-28 1990-08-14 Sanofi Process for the depolymerization and sulfation of polysaccharides
US4855416A (en) * 1983-07-25 1989-08-08 Polydex Pharmaceuticals, Ltd Method for the manufacture of dextran sulfate and salts thereof
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
GB8504253D0 (en) * 1985-02-19 1985-03-20 Ici Plc Electrostatic spraying apparatus
DE3601136A1 (de) * 1986-01-16 1987-07-23 Max Planck Gesellschaft Hemmstoffe der reversen transkriptase fuer prophylaxe und therapie von retrovirus-infektionen in saeugetieren
EP0240098A3 (en) * 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo and polysaccharides for the treatment of diseases caused by retroviruses
US5672334A (en) * 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
ZA878877B (en) * 1986-11-29 1988-05-24 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Treatment of diseases caused by viruses
EP0285357A3 (en) * 1987-03-31 1989-10-25 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Control of retroviruses
ES2024641B3 (es) * 1987-05-20 1992-03-01 Kk Ueno Seiyaku Oyo Kenkyujo Preservativo.
EP0293826A3 (en) * 1987-06-02 1989-05-10 Stichting REGA V.Z.W. Therapeutic and prophylactic application of sulfated polysaccharides against aids
DE3815221C2 (de) * 1988-05-04 1995-06-29 Gradinger F Hermes Pharma Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen
JP2681653B2 (ja) * 1988-05-13 1997-11-26 台糖株式会社 抗エイズウィルス剤
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
US5272261A (en) * 1989-01-11 1993-12-21 Merrell Dow Pharmaceuticals Inc. Preparation of sulfated polysaccharide fractions
IT1229203B (it) * 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
CA2013843A1 (en) * 1989-04-06 1990-10-06 Junko Nozaki Antiviral composition
US5120548A (en) * 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
FR2657884B1 (fr) * 1990-02-05 1994-09-02 Tm Innovation Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.
US5227372A (en) * 1990-03-07 1993-07-13 Children's Medical Center Corporation Method for retaining ophthalmological agents in ocular tissues
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
GB9020861D0 (en) * 1990-09-25 1990-11-07 Ml Lab Plc Pharmaceutical compositions
ES2027528A6 (es) * 1990-12-17 1992-06-01 Andromaco Lab Procedimiento para la obtencion de polimeros con actividad antiviral.
AU1052492A (en) * 1991-01-31 1992-08-06 Farmitalia Carlo Erba S.R.L. Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent
DE4121389A1 (de) * 1991-02-07 1992-08-13 Nattermann A & Cie Pharmazeutisches produkt zur behandlung von viruserkrankungen
US5221669A (en) * 1991-04-19 1993-06-22 The United States Of America As Represented By The Department Of Health And Human Services Antiviral compositions containing α-cyclodextrin sulfates alone and in combination with other known antiviral agents and glucocorticoids and methods of treating viral infections
US5705178A (en) * 1991-05-31 1998-01-06 Gliatech, Inc. Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
CA2146988A1 (en) * 1992-10-13 1994-04-28 Gideon Strassmann Treatment of cachexia and inhibition of il-6 activity
US5459257A (en) * 1993-01-11 1995-10-17 Dainippon Ink And Chemicals, Inc. Sulfated oligoglycoside acylate and antiviral agent containing the same as active ingredient
US5591767A (en) * 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
US5514665A (en) * 1993-12-30 1996-05-07 University Of British Columbia Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
IT1270594B (it) * 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US5594047A (en) * 1995-02-17 1997-01-14 Eastman Kodak Company Method for forming photographic dispersions comprising loaded latex polymers
EP0814860B1 (en) * 1995-03-14 1999-11-03 Siemens Aktiengesellschaft Ultrasonic atomizer device with removable precision dosating unit
US5970974A (en) * 1995-03-14 1999-10-26 Siemens Aktiengesellschaft Dosating unit for an ultrasonic atomizer device
US5658893A (en) * 1995-03-29 1997-08-19 Abbott Laboratories Method for inhibition of rotavirus infection with carrageenan
JP3116341B2 (ja) * 1995-04-26 2000-12-11 新神戸電機株式会社 積層板および積層板基材用ガラス織布、ならびに積層板の使用法
US6063773A (en) * 1995-09-29 2000-05-16 Polydex Pharmaceuticals Ltd. Cellulose sulfate for use as antimicrobial and contraceptive agent
US5981509A (en) * 1997-05-20 1999-11-09 Shiseido Company, Ltd. Preparation for prophylaxis or treatment of renal diseases containing sulfated polysaccharide

Similar Documents

Publication Publication Date Title
JP2006502129A5 (enExample)
DK1141235T3 (da) Bifidobakterier til behandling af inflammatorisk sygdom
JP2003522732A5 (enExample)
ATE491436T1 (de) Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen
ATE336995T1 (de) Aminocyclohexenchinoline und ihre azaisosterischen analoga mit antibakterieller wirkung
BR0211442A (pt) Cepas de bifidobacterium probióticas
JP2006328398A5 (enExample)
EP1545599A4 (en) IMMUNOGENIC COMPOSITIONS AND ITS DIAGNOSTIC AND THERAPEUTIC USES
ATE272628T1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
DE69500618D1 (de) Oligonukleotide mit wirkung gegen das respiratorische synzytial virus
BRPI0409609A (pt) mediadores do transporte reverso de colesterol para o tratamento da hipercolesterolemia
JP2006507295A5 (enExample)
WO2000059490A3 (en) Immunomodulating composition for use especially in the treatment of inflammations, infections and surgical adhesions
JP2005525089A5 (enExample)
FR2846327B1 (fr) Derives de n-benzodioxolyl, n-benzodioxanyl et n-benzodioxepinyl arylcarboxamides utilisables dans le traitement de dyslipidemies et compositions pharmaceutiques les contenant.
WO2004054603A3 (en) Use of beta-defensins for treating hiv infections
FR2882750B1 (fr) Derives de 1,2,4-triazines, leur preparation et leur application en therapeutique humaine
FR2887548B1 (fr) Derives de 4,5-diarylpyrrole, leur preparation et leur application en therapeutique
ES2068469T3 (es) Agente para la proteccion de plantas contra el ataque por microorganismos.
ATE340182T1 (de) Sucroseoctasulphat silber saltz
RU2001120324A (ru) Средство, обладающее противоанемической и иммуномодуляторной активностью
JP2006514072A5 (enExample)
FR2866339B1 (fr) Derives de 1,2,4-triazines, leur preparation et leur application en therapeutique humaine
RU2003107625A (ru) Способ моделирования спаечной болезни
RU2004101641A (ru) Способ лечения красного плоского лишая